nimodipine has been researched along with Idiopathic Parkinson Disease in 5 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nimodipine treatment in this model did not impact dopamine graft survival but allowed for increased graft reinnervation of striatum." | 1.36 | Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. ( Collier, TJ; Levine, ND; O'Malley, JA; Soderstrom, KE; Sortwell, CE; Steece-Collier, K, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, B | 1 |
| Wang, M | 1 |
| Gao, D | 1 |
| Xing, S | 1 |
| Li, L | 1 |
| Liu, L | 1 |
| Zhao, M | 1 |
| Qi, X | 1 |
| Dai, K | 1 |
| Bezard, E | 1 |
| Soderstrom, KE | 1 |
| O'Malley, JA | 1 |
| Levine, ND | 1 |
| Sortwell, CE | 1 |
| Collier, TJ | 1 |
| Steece-Collier, K | 1 |
| Bean, BP | 1 |
| Marchand, L | 1 |
5 other studies available for nimodipine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Combining nanoscale magnetic nimodipine liposomes with magnetic resonance image for Parkinson's disease targeting therapy.
Topics: Animals; Blood-Brain Barrier; Drug Delivery Systems; Drug Liberation; Drug Stability; Humans; Liposo | 2017 |
Treating Parkinson's disease: preserve the spines! (Commentary on Soderstrom et al.).
Topics: Animals; Calcium Channel Blockers; Cell Transplantation; Dendritic Spines; Humans; Neurons, Efferent | 2010 |
Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Calcium Channel Blockers; Cell Transplantation; Den | 2010 |
Neurophysiology: stressful pacemaking.
Topics: Animals; Antiparkinson Agents; Calcium; Calcium Channels, L-Type; Disease Models, Animal; Disease Pr | 2007 |
[Treatment of essential tremor].
Topics: Anti-Anxiety Agents; Anti-Dyskinesia Agents; Botulinum Toxins; Humans; Hypnotics and Sedatives; Meth | 1995 |